Finance

Lists
Why is RVV down 25.00%?
Dive Deeper
RVV:CNSX
Revive Therapeutics Ltd
CA$0.015
-25.00%
(-0.0050) 1D
Nov 13, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for RVV...
Open
CA$0.02
High
CA$0.02
Low
CA$0.02
Mkt. cap
6.54M
Avg. vol.
81.76K
Volume
10.00K
52-wk high
CA$0.08
52-wk low
CA$0.00
EPS
-CA$0.00
Open
CA$0.02
High
CA$0.02
Low
CA$0.02
Mkt. cap
6.54M
Avg. vol.
81.76K
Volume
10.00K
52-wk high
CA$0.08
52-wk low
CA$0.00
EPS
-CA$0.00
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
200.14K
283.25K
242.05K
98.66K
Operating expense
220.13K
283.30K
463.87K
98.71K
Total operating expenses
220.13K
283.30K
463.87K
98.71K
Operating income
-220.13K
-283.30K
-463.87K
-98.71K
Other non operating income
-
-
-
-
EBT including unusual items
-281.75K
-238.72K
-506.50K
3.33K
EBT excluding unusual items
-281.75K
-234.70K
-506.50K
-78.44K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-281.75K
-238.72K
-506.50K
3.33K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
277.00
-
-
-
Interest expense
-
-
-
-
Net interest expenses
277.00
-
-
-
Depreciation and amortization charges
46.00
48.00
47.00
48.00
EBITDA
-220.08K
-283.25K
-463.82K
-98.66K
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps